市场调查报告书
商品编码
1403493
到 2030 年居家照护氧气浓缩机市场预测:按产品类型、行销类型、技术、最终用户和地区进行的全球分析Homecare Oxygen Concentrators Market Forecasts to 2030 - Global Analysis By Product, Marketing Type, Technology, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球居家照护氧气浓缩机市场规模为 18 亿美元,预计在预测期内将以 8% 的复合年增长率增长,到 2030 年达到 31 亿美元。
居家照护氧气浓缩机市场是指提供携带式和固定式设备的行业,旨在为患有呼吸系统疾病的人在舒适的家中提供浓缩氧气。行业领导者提供各种具有不同功能和流量的产品,以满足不同类型患者的需求。
根据世界卫生组织 (WHO) 统计,2019 年全球约有 323 万人死于慢性阻塞性肺病(COPD)。
随着老年人口的增加,需要氧气疗法的呼吸系统疾病(例如慢性阻塞性肺病(COPD))的盛行率不断增加。对于需要额外氧气的人来说,居家照护氧气浓缩机提供了一个实用且有效的解决方案,可以在舒适的家中管理他们的医疗状况。此外,这些人口趋势正在增加对家庭医疗保健解决方案的需求。
居家照护氧气浓缩机对消费者来说可能很昂贵,限制了那些买不起的人的使用。阻碍广泛普及的另一个因素是医疗保险公司的报销问题。家庭长期使用所需的医疗设备成本高昂,导致一些患者无法购买,阻碍了市场成长。因此,为了克服这一障碍并确保扩大居家照护氧气浓缩机的使用范围,需要解决负担能力问题并改善报销政策。
随着越来越多的老年人更喜欢在自己舒适的家中养老,对方便可靠的家庭氧气疗法解决方案的需求正在迅速增加。居家照护氧气浓缩机取代了笨重的氧气瓶,提供了一种轻巧且方便的替代方案,可以保持患者的自由和活动能力。製造商可以透过开发无噪音、节能且轻巧的设备来受益于技术进步,以满足对高效家庭呼吸护理不断增长的需求。全球对医疗保健领域去中心化和经济高效解决方案的重视正在推动该市场的扩张。
传统的居家照护氧气浓缩机正面临着可穿戴式和便携式供氧技术以及可节省成本和便利的替代技术兴起的竞争。医疗保健行业的报销问题和监管变化也可能影响市场扩张。居家照护对氧气浓缩机的需求可能会受到远端医疗服务和远端患者监护的影响。为了降低新市场威胁带来的风险,该行业的製造商必须保持弹性,以适应不断发展的技术。
由于病毒引起的呼吸系统併发症激增,对氧气疗法用品(例如用于居家照护的氧气浓缩机)的需求正在增加。随着越来越多的人选择家庭长期氧气疗法治疗解决方案,需求不断增长,市场正在扩大。为了满足这项需求,製造商正在迅速提高产量,便携式、易于使用的设计创新也越来越受到关注。此外,疫情也推动了远端医疗服务的普及,透过促进呼吸系统疾病的远端监测和管理,影响了居家照护氧气浓缩机市场。
由于其便携性和便利性的优势,携带式家庭护理氧气浓缩机市场正在居家照护居家照护氧气浓缩机市场中经历显着增长。患有呼吸系统疾病的患者更喜欢携带式氧气浓缩机,因为它们可以让他们在接受必要的氧气治疗时保持活动状态。此外,人们对家庭氧气疗法的广泛了解正在推动对携带式解决方案的需求并扩大市场。
由于效率和便携性的提高,居家照护氧气浓缩机市场的脉衝流部分正在经历显着增长。脉衝流设备仅在使用者吸气时输送氧气,从而最大限度地提高氧气消费量并延长浓缩器的使用寿命。这项功能对于偶尔需要氧气的患者来说更经济、节能。脉衝流浓缩器在居家照护氧气浓缩机领域正在获得市场份额,这主要是由于家庭医疗保健解决方案的成长趋势。
由于人口老化、呼吸系统疾病发病率增加以及消费者对家庭医疗保健选择意识的提高等因素,亚太地区(APAC)居家照护氧气浓缩机市场正在快速增长。由于携带式氧气浓缩机的改进和技术创新,市场正在不断扩大。此外,持续的 COVID-19 爆发增加了对呼吸护理产品的需求,这正在推动亚太地区市场的发展。领先的医疗保健提供者和行业参与者之间的合作也有助于推动这些设备的市场动力。
对家庭医疗保健的日益重视、人口老化以及呼吸系统疾病盛行率的上升,正在促进欧洲居家照护氧气浓缩机市场的良好成长。 COVID-19 大流行凸显了呼吸照护的重要性,导致居家照护对氧气浓缩机的需求增加。支持家庭护理服务的医疗基础设施和优惠的报销政策也促进了市场的强劲成长。
According to Stratistics MRC, the Global Homecare Oxygen Concentrators Market is accounted for $1.8 billion in 2023 and is expected to reach $3.1 billion by 2030 growing at a CAGR of 8% during the forecast period. The Homecare Oxygen Concentrators market refers to the industry that provides portable and stationary devices designed to deliver concentrated oxygen to individuals with respiratory conditions in the comfort of their homes. Major industry players provide a variety of products with different features and flow rates to meet the needs of different types of patients.
According to the World Health Organization, nearly 3.23 million deaths were caused due to the Chronic Obstructive Pulmonary Disease (COPD), globally, in 2019.
As the elderly population increases, there is a rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and other respiratory conditions that necessitate oxygen therapy. For those in need of extra oxygen, homecare oxygen concentrators provide a practical and efficient solution that enables them to manage their conditions from the comfort of their own homes. Additionally, the demand for home healthcare solutions is increasing due to this demographic trend.
Homecare oxygen concentrators can be expensive for consumers, limiting accessibility for individuals with lower financial means. Further impeding widespread adoption could be reimbursement challenges from health insurance companies. The expense of these necessary medical devices for long-term use at home prevents some patients from affording them, which hinders market growth. Therefore, overcoming this barrier and guaranteeing greater access to homecare oxygen concentrators requires addressing affordability issues and improving reimbursement policies.
As more elderly individuals prefer to age in place, the demand for convenient and reliable home oxygen therapy solutions has surged. In place of bulky oxygen tanks, homecare oxygen concentrators provide a lightweight, convenient substitute that preserves patients' freedom and mobility. Manufacturers can benefit from technological advancements by creating devices that are noise-free, energy-efficient, and lightweight, which will help meet the growing demand for efficient home respiratory care. The growing emphasis on healthcare decentralization and cost-effective solutions worldwide is driving this market's expansion.
Conventional home oxygen concentrators face competition from emerging wearable and portable oxygen delivery technologies, as well as possible cost- and convenience-saving alternatives. The healthcare industry's reimbursement problems and regulatory changes could also affect the market's expansion. The need for homecare oxygen concentrators may be impacted by the move toward telehealth services and remote patient monitoring. To reduce the risk posed by emerging market threats, manufacturers in this industry must remain flexible in their adaptation to evolving technologies.
The need for oxygen therapy supplies, such as home oxygen concentrators, has increased due to the virus's surge in respiratory complications. The market has expanded as a result of the rising demand, with more people choosing home-based solutions for long-term oxygen therapy. To meet this demand, manufacturers have seen a spike in production, and innovations in portable and user-friendly designs are receiving more attention. Furthermore, the pandemic has expedited the uptake of telehealth services, impacting the homecare oxygen concentrator market by encouraging remote respiratory condition monitoring and management.
Because of its benefits of portability and convenience, the portable home oxygen concentrator market within the homecare oxygen concentrator market has experienced significant growth. Patients with respiratory disorders like portable oxygen therapy units because they enable them to continue living an active lifestyle while receiving vital oxygen treatment. In addition, a greater knowledge of the advantages of home oxygen therapy have fueled demand for portable solutions and expanded the market.
The pulse flow segment in the Homecare Oxygen Concentrators market has experienced substantial growth due to its enhanced efficiency and portability. By delivering oxygen only when the user inhales, pulse flow devices maximize oxygen consumption and prolong concentrator life. Because of this feature, they are more economical and energy-efficient for patients with sporadic oxygen needs. Pulse flow concentrators' growing market share in the homecare oxygen concentrators sector is largely due to the growing trend toward at-home healthcare solutions.
The Asia-Pacific (APAC) homecare oxygen concentrator market has grown rapidly due to factors like an aging population, a rise in respiratory disorders, and increased consumer awareness of at-home healthcare options. The market has grown as a result of improvements in portable oxygen concentrators and technological breakthroughs. In addition, the ongoing COVID-19 pandemic has increased the need for respiratory care supplies, which is driving the APAC market. Partnerships between major healthcare providers and industry players have also helped these devices gain traction in the market.
A growing emphasis on home-based healthcare, an aging population, and the rising prevalence of respiratory disorders have all contributed to Europe's Homecare Oxygen Concentrators market's lucrative growth. The need for homecare oxygen concentrators has increased as a result of the COVID-19 pandemic's emphasis on the significance of respiratory care. The healthcare infrastructure that supports homecare services and favorable reimbursement policies have also contributed to the market's strong growth.
Some of the key players in Homecare Oxygen Concentrators market include Air Water Inc, AVIC Jianghang, Beijing North Star, Besco Medical Co., BOC Healthcare (The Linde Group), Chart Industries Inc , Drive DeVibiss Healthcare Inc, Foshan Kaiya, GCE Group, Inogen Inc, Inova Labs Inc. (ResMed), Invacare, Koninklijke Philips N.V., Longfian Scitech Co, NIDEK Medical Products, Inc, O2 Concepts , Philips Respironics, Precision Medical Inc , Teijin and Yuwell (iangsu Yuyue Medical Equipment and Supply Co., Ltd.)
In August 2023, Chart Industries, Inc, a leading global engineering design firm, announced that it has executed a Memorandum of Understanding ("MOU") with 8 Rivers Capital, LLC, to evaluate 8 Rivers' portfolio of proprietary licensable technologies and processes and identify where Chart's technologies and systems can complement or bring added value to the 8 Rivers offerings. This collaboration includes developing equipment for 8 Rivers technologies backed up by Chart's decades of experience in the design and manufacture of cryogenic, compression and process technologies, to assist 8 Rivers in delivering a reliable and cost-effective solution to their customers.
In July 2023, Inogen has signed a definitive agreement for the acquisition of France-based company Physio-Assist in a deal valued at nearly $45m, to bolster its respiratory product portfolio. As per the deal, Physio-Assist is entitled to receive nearly $32m in cash from Inogen at closing, as well as payments on meeting milestones linked to clearance from the Food and Drug Administration for the device.